Submit Deal

Submit Deal

Cover Image Thomas Cannell

Thomas Cannell

President and CEO at SESEN BIO

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 381 M

Avg. Deal Size£ 381 M

Market Context

Sort

21 Sep 2022|United States|Pharmaceuticals

Target: CARISMA THERAPEUTICS INC

Bidder: SESEN BIO

11 Service Providers

7 Target | 4 Bidder

15 Dealmakers

3 Target | 12 Bidder

£ 380 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite